AnaptysBio (ANAB) Stock
AnaptysBio (ANAB) closed at $45.61 on Nov 17, 2026; its Tenet Score is 53 of 100 against 340 Healthcare peers.
17 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $45.61
- Nov 17, 2026
- Market cap
- $1.4B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 32.96 – 73.30
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 53/100
- Mixed · 340 Healthcare peers
Industry: Drugs
AnaptysBio Inc scores 53/100. Mixed. Strongest on financial health, value is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ~ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Quality Compounder
13F flows & insider trades land here.
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R)…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Intellia Therapeutics IncNTLA | 41 | $1.4B |
| UroGen Pharma LtdURGN | 44 | $1.4B |
| AlvotechALVO | 41 | $1.4B |
| Novavax, Inc.NVAX | 37 | $1.3B |
| Taysha Gene Therapies IncTSHA | 58 | $1.3B |
| Ocular Therapeutix IncOCUL | 51 | $1.3B |
| Innoviva IncINVA | 73 | $1.3B |
| Absci CorpABSI | 39 | $1.3B |
| Mineralys Therapeutics IncMLYS | 55 | $1.3B |
| Mannkind CorpMNKD | 29 | $1.3B |
Common questions
What sector and industry is AnaptysBio in?
AnaptysBio is in the Healthcare sector and the Drugs industry.
What is AnaptysBio's Tenet Score?
AnaptysBio's Tenet Score is 53 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




